Boulogne, France

Anne Gruaz-Guyon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Immunotech Partners. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Gruaz-Guyon. Retrieved from https://idiyas.com/inventor/anne-gruaz-guyon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne Gruaz-Guyon: Innovator in Hydrophilic Derivatives

Introduction

Anne Gruaz-Guyon is a notable inventor based in Boulogne, France. She has made significant contributions to the field of diagnostics and therapeutics through her innovative work on hydrophilic derivatives. Her research has implications for both medical diagnostics and treatment applications.

Latest Patents

Anne Gruaz-Guyon holds a patent for "Hydrophilic derivatives, their application to diagnosis and to therapeutics." This patent involves derivatives that comprise two hydrophilic haptens and an effector group, which may include a radioactive isotope or an active principle. These components are linked by a connecting bridge, making them applicable in diagnostic and therapeutic kits, as well as immunological reagents.

Career Highlights

Throughout her career, Anne has worked with various companies, including Immunotech Partners and Iason GmbH. Her expertise in the field has allowed her to develop innovative solutions that enhance diagnostic capabilities and therapeutic options.

Collaborations

Anne has collaborated with notable professionals in her field, including Jacques Barbet and Michel Delaage. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Anne Gruaz-Guyon is a pioneering inventor whose work on hydrophilic derivatives has the potential to transform diagnostic and therapeutic practices. Her contributions to the field are invaluable and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…